Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Gray

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Immunology|August 1, 1988
Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosusM Linker-Israeli, J D Gray, F P Quismorio, et al.
Clinical and Experimental Dermatology|September 1, 1992
The use of calcipotriol in HIV-related psoriasisJ D Gray, W Bottomley, A M Layton, et al.
Lupus|April 7, 1999
Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-betaK Ohtsuka, J D Gray, F P Quismorio, et al.
Cellular Immunology|May 1, 1999
Nitric oxide inhibits the proliferation of T-helper 1 and 2 lymphocytes without reduction in cytokine secretionR C van der Veen, T A Dietlin, L Pen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 1998
Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosusK Ohtsuka, J D Gray, M M Stimmler, et al.
Clinical and Experimental Immunology|March 1, 1987
Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosusJ D Gray, A Lash, A C Bakke, et al.
Arthritis and Rheumatism|May 1, 1997
Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interactionD A Horwitz, F L Tang, M M Stimmler, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36J M Pelham, J D Gray, G R Flannery, et al.
Cellular Immunology|October 15, 1988
Generation of lymphokine-activated killer cell activity from non-NK precursor cellsF J Ramsdell, R A Lindemann, H Y Shau, et al.
Cellular Immunology|February 13, 2001
Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-gamma is essential but insufficientR C van der Veen, T A Dietlin, L Pen, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Immunology|August 1, 1988
Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosusM Linker-Israeli, J D Gray, F P Quismorio, et al.
Clinical and Experimental Dermatology|September 1, 1992
The use of calcipotriol in HIV-related psoriasisJ D Gray, W Bottomley, A M Layton, et al.
Lupus|April 7, 1999
Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-betaK Ohtsuka, J D Gray, F P Quismorio, et al.
Cellular Immunology|May 1, 1999
Nitric oxide inhibits the proliferation of T-helper 1 and 2 lymphocytes without reduction in cytokine secretionR C van der Veen, T A Dietlin, L Pen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 1998
Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosusK Ohtsuka, J D Gray, M M Stimmler, et al.
Clinical and Experimental Immunology|March 1, 1987
Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosusJ D Gray, A Lash, A C Bakke, et al.
Arthritis and Rheumatism|May 1, 1997
Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interactionD A Horwitz, F L Tang, M M Stimmler, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36J M Pelham, J D Gray, G R Flannery, et al.
Cellular Immunology|October 15, 1988
Generation of lymphokine-activated killer cell activity from non-NK precursor cellsF J Ramsdell, R A Lindemann, H Y Shau, et al.
Cellular Immunology|February 13, 2001
Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-gamma is essential but insufficientR C van der Veen, T A Dietlin, L Pen, et al.
Pageof 8